FDA Expands Use of Antiangiogenic to Kidney Cancer
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the antiangiogenic...
Category: Research
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the antiangiogenic...
In a study presented at the AACR Annual Meeting 2016 on April 19, researchers engineered an organic bispecific adaptor...
Earlier this month, the U.S. Food and Drug Administration (FDA) approved a new colorectal cancer screening test, the ‘System,...
Data presented at the AACR Annual Meeting 2016, on April 19, showed that a microdevice about the size of...
Immunotherapy was one of the hottest topics at last year’s AACR Annual Meeting, and this year the trend is...
Last week, the U.S. Food and Drug Administration (FDA) added another therapeutic to the armamentarium for hematologist-oncologists when it...
A recent study in the AACR’s journal Cancer Epidemiology, Biomarkers & Prevention found an association between glycemic index (a...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of crizotinib (Xalkori)...
March is Colorectal Cancer Awareness Month. About 134,490 people are estimated to be diagnosed with and about 49,190 are...
In a study published in the AACR’s journal Cancer Discovery in December, a team of researchers from the Perelman...